ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller +8 more
wiley +1 more source
Effect Of Demographic And Clinical Variables On Nt-Probnp
Pakistan Journal of Medicine and Dentistry, 2018 Background: A number of demographic and clinical variables have an effect on NT-proBNP, which has been used as a serological marker for evaluating cardiovascular disease. This study was done to evaluate the effect of these confounding variables on NT-
Sofia Amjad, Sobia Hassan, Amna Faruqi
doaj
NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function [PDF]
, 2003 M. Bay
openalex +1 more source
American journal of hematology/oncology, 2016 Multiple myeloma (MM) patient frailty has been delineated primarily by age and ECOG performance score (PS) and recently by the IMWG frailty score based on functional status [Activity of Daily Living (ADL) and Instrumental‐ADL scores], comorbidities ...
P. Milani +19 more
semanticscholar +1 more source
Highly sensitive detection of NT-proBNP by molecular motor
Genes & Diseases, 2017 FoF1-ATPase is an active rotary motor, and generates three-ATP for each rotation. At saturated substrate concentration, the motor can achieve about 103 r.p.m, which means one motor can generate about 105 ATP molecules during 30 min. Here, we constituted a novel nanodevice with a molecular rotary motor and a "battery", FoF1-ATPase and chromatophore, and
Yao-Gen Shu, Jie Ying Zhang
openaire +4 more sources
The predictive value of preoperative B-type natriuretic peptide in children undergoing cardiac surgery [PDF]
, 2015 Introduction: B-type natriuretic peptide (BNP) is a biomarker of myocardial stress. In children, the value of preoperative BNP on postoperative outcome is unclear.
Boulos, T.
core
N-terminal pro-B-type natriuretic peptide and risk of future cognitive impairment in the REGARDS cohort [PDF]
, 2016 Background: Improved understanding of the etiology of cognitive impairment is needed to develop effective preventive interventions. Higher amino-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac dysfunction associated with ...
Callas, Peter W. +7 more
core +1 more source
Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe
ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani +11 more
wiley +1 more source
Emergency Medicine International, 2013 Background. The NT-ProBNP/BNP test has been validated as a marker for determining the etiology of acute dyspnea. In the setting of end-stage renal disease on hemodialysis (ESRD on HD), the utility of the NT-ProBNP/BNP test has not been validated.
Shaffer R. S. Mok +3 more
doaj +1 more source
Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease [PDF]
, 2003 Thomas Mueller +3 more
openalex +1 more source